Annual Working Capital
$228.52 M
+$37.73 M+19.78%
31 December 2023
Summary:
Fulcrum Therapeutics annual working capital is currently $228.52 million, with the most recent change of +$37.73 million (+19.78%) on 31 December 2023. During the last 3 years, it has risen by +$21.73 million (+10.51%). FULC annual working capital is now at all-time high.FULC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$252.98 M
-$14.61 M-5.46%
30 September 2024
Summary:
Fulcrum Therapeutics quarterly working capital is currently $252.98 million, with the most recent change of -$14.61 million (-5.46%) on 30 September 2024. Over the past year, it has increased by +$24.46 million (+10.70%). FULC quarterly working capital is now -12.29% below its all-time high of $288.42 million, reached on 31 March 2023.FULC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +10.7% |
| 3 y3 years | +10.5% | +22.3% |
| 5 y5 years | +159.8% | +187.7% |
FULC Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +19.8% | -12.3% | +66.3% |
| 5 y | 5 years | at high | +159.8% | -12.3% | +260.7% |
| alltime | all time | at high | >+9999.0% | -12.3% | +461.9% |
Fulcrum Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $252.98 M(-5.5%) |
| June 2024 | - | $267.59 M(+29.1%) |
| Mar 2024 | - | $207.26 M(-9.3%) |
| Dec 2023 | $228.52 M(+19.8%) | $228.52 M(-8.0%) |
| Sept 2023 | - | $248.41 M(-7.4%) |
| June 2023 | - | $268.14 M(-7.0%) |
| Mar 2023 | - | $288.42 M(+51.2%) |
| Dec 2022 | $190.79 M(-7.7%) | $190.79 M(-10.4%) |
| Sept 2022 | - | $213.03 M(+40.0%) |
| June 2022 | - | $152.13 M(-16.3%) |
| Mar 2022 | - | $181.78 M(-12.1%) |
| Dec 2021 | $206.80 M | $206.80 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $225.59 M(+112.8%) |
| June 2021 | - | $106.00 M(-14.8%) |
| Mar 2021 | - | $124.36 M(+34.0%) |
| Dec 2020 | $92.78 M(+5.5%) | $92.78 M(-12.2%) |
| Sept 2020 | - | $105.66 M(-12.6%) |
| June 2020 | - | $120.84 M(+72.3%) |
| Mar 2020 | - | $70.14 M(-20.2%) |
| Dec 2019 | $87.94 M(+25.9%) | $87.94 M(-9.0%) |
| Sept 2019 | - | $96.64 M(+114.6%) |
| June 2019 | - | $45.02 M(-24.1%) |
| Mar 2019 | - | $59.31 M(-15.1%) |
| Dec 2018 | $69.87 M(-4928.3%) | $69.87 M |
| Dec 2017 | -$1.45 M | - |
FAQ
- What is Fulcrum Therapeutics annual working capital?
- What is the all time high annual working capital for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly working capital year-on-year change?
What is Fulcrum Therapeutics annual working capital?
The current annual working capital of FULC is $228.52 M
What is the all time high annual working capital for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual working capital is $228.52 M
What is Fulcrum Therapeutics quarterly working capital?
The current quarterly working capital of FULC is $252.98 M
What is the all time high quarterly working capital for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly working capital is $288.42 M
What is Fulcrum Therapeutics quarterly working capital year-on-year change?
Over the past year, FULC quarterly working capital has changed by +$24.46 M (+10.70%)